Jan 08, 2018 13:31 pm UTC| Business
WATERTOWN, Mass., Jan. 08, 2018 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technologies, today announced it has submitted its New Drug Application (NDA)...
Jan 08, 2018 13:31 pm UTC| Business
NEW YORK, Jan. 08, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of US Ecology, Inc....
Cerner to Release Fourth Quarter 2017 Earnings Results February 6
Jan 08, 2018 13:30 pm UTC| Business
KANSAS CITY, Mo., Jan. 08, 2018 -- Cerner Corporation (Nasdaq:CERN) today announced it will release its fourth quarter 2017 earnings results after the market closes Tuesday, Feb. 6. Following the release, the company...
Jan 08, 2018 13:30 pm UTC| Business
Milestone for antibody targeting TIM-3 triggers $5 million payment to Five Prime BMS extends research collaboration term for discovery, development and commercialization for therapeutics in three immune checkpoint...
Jan 08, 2018 13:30 pm UTC| Business
VANCOUVER, British Columbia, Jan. 08, 2018 -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9), the innovator and pioneer behind neuenergy®, is pleased to announce it...
Oxford Immunotec Announces Preliminary Revenue for Fourth Quarter and Full Year 2017
Jan 08, 2018 13:30 pm UTC| Business
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 08, 2018 -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that based on preliminary unaudited financial data,...
CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results
Jan 08, 2018 13:30 pm UTC| Business
BRISBANE, Calif., Jan. 08, 2018 -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...